Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001615219-25-000185
Filing Date
2025-11-24
Accepted
2025-11-24 07:59:44
Documents
3
Period of Report
2025-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1763989180.html 3  
1 FORM 3 wk-form3_1763989180.xml 3 7905
2 EX-24 salarius-section16powero.htm EX-24 4793
3 salarius-section16powero001.jpg GRAPHIC 282528
  Complete submission text file 0001615219-25-000185.txt   403470
Mailing Address C/O GLYCOGENESYS INC 31ST JAMES AVE BOSTON MA 02116
Business Address
PIERCE FREDERICK II (Reporting) CIK: 0001229055 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36812 | Film No.: 251509614

Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)